ARCHIVES

Nine contracts For Automated Pap Test Systems Total $1.7 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 37 | October 18, 1974

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Young Investigators Hold Their Own

September 28, 1979

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

DCCR Advisory Committee Delays Planned Expansion Of Promising Community Clinical Oncology Program

July 21, 1978

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982